M L Brandi

Summary

Affiliation: University of Florence
Country: Italy

Publications

  1. ncbi When the government actively faces the burden of osteoporosis: the Italian experience
    Maria Luisa Brandi
    Department of Internal Medicine, University of Florence, Florence, Italy
    Arch Osteoporos 7:21-4. 2012
  2. ncbi Drugs for bone healing
    Maria Luisa Brandi
    University of Florence, Department of Surgery and Translational Medicine, Mineral and Bone Metabolic Diseases Unit, Largo Palagi, 1, 50100 Florence, Italy
    Expert Opin Investig Drugs 21:1169-76. 2012
  3. ncbi Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study
    Francesco Massart
    Department of Internal Medicine, University of Florence, Florence, Italy
    Reprod Biol Endocrinol 7:32. 2009
  4. ncbi Multiple endocrine neoplasia type 2
    Francesca Marini
    Regional Center for Hereditary Endocrine Tumors, Department of Internal Medicine, University of Florence, Florence, Italy
    Orphanet J Rare Dis 1:45. 2006
  5. ncbi Multiple endocrine neoplasia type 1
    Francesca Marini
    Regional Center for Hereditary Endocrine Tumours, Department of Internal Medicine, University of Florence, Florence, Italy
    Orphanet J Rare Dis 1:38. 2006
  6. ncbi The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study
    Umberto Tarantino
    Division of Orthopaedics and Traumatology, Tor Vergata Foundation University Hospital, University of Rome, Tor Vergata, Viale Oxford 81, Rome, 00133, Italy
    Arthritis Res Ther 12:R226. 2010
  7. ncbi Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family
    Alberto Falchetti
    Department of Internal Medicine, University of Florence, Florence, Italy
    Arthritis Res Ther 7:R1289-95. 2005
  8. ncbi Management of post-menopausal osteoporosis: something new on the horizon?
    M L Brandi
    Department of Internal Medicine, University of Florence, Florence, Italy
    J Endocrinol Invest 26:170-3. 2003
  9. ncbi Genetics of hypoparathyroidism and pseudohypoparathyroidism
    M L Brandi
    Unit of Bone and Mineral Metabolism, Department of Internal Medicine, University of Florence, Medical School, Viale Pieraccini, 6 50139 Florence, Italy
    J Endocrinol Invest 34:27-34. 2011
  10. ncbi Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis
    M L Brandi
    University of Florence Medical School, Florence, Italy
    Curr Med Res Opin 26:2553-63. 2010

Detail Information

Publications93

  1. ncbi When the government actively faces the burden of osteoporosis: the Italian experience
    Maria Luisa Brandi
    Department of Internal Medicine, University of Florence, Florence, Italy
    Arch Osteoporos 7:21-4. 2012
    ..THE FUTURE OF OSTEOPOROSIS IN ITALY: We hope that the example of Italy would serve as an inspiration to those countries where the history of osteoporosis only recently began...
  2. ncbi Drugs for bone healing
    Maria Luisa Brandi
    University of Florence, Department of Surgery and Translational Medicine, Mineral and Bone Metabolic Diseases Unit, Largo Palagi, 1, 50100 Florence, Italy
    Expert Opin Investig Drugs 21:1169-76. 2012
    ..However, future clinical trials will offer the possibility to obtain data that will make possible the registration of a drug as a "healer."..
  3. ncbi Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study
    Francesco Massart
    Department of Internal Medicine, University of Florence, Florence, Italy
    Reprod Biol Endocrinol 7:32. 2009
    ..Common variants in the genes encoding for estrogen receptor alpha (ESR1) and beta (ESR2) are proposed as candidates for influencing bone phenotypes at the population level...
  4. ncbi Multiple endocrine neoplasia type 2
    Francesca Marini
    Regional Center for Hereditary Endocrine Tumors, Department of Internal Medicine, University of Florence, Florence, Italy
    Orphanet J Rare Dis 1:45. 2006
    ..At present, surgical treatment offers the only chance of cure and therefore, early clinical and genetic detection and prophylactic surgery in subjects at risk are the main therapeutic goal...
  5. ncbi Multiple endocrine neoplasia type 1
    Francesca Marini
    Regional Center for Hereditary Endocrine Tumours, Department of Internal Medicine, University of Florence, Florence, Italy
    Orphanet J Rare Dis 1:38. 2006
    ....
  6. ncbi The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study
    Umberto Tarantino
    Division of Orthopaedics and Traumatology, Tor Vergata Foundation University Hospital, University of Rome, Tor Vergata, Viale Oxford 81, Rome, 00133, Italy
    Arthritis Res Ther 12:R226. 2010
    ..We aimed to assess the incidence and hospitalization rate of hip and "minor" fragility fractures in the Italian population...
  7. ncbi Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family
    Alberto Falchetti
    Department of Internal Medicine, University of Florence, Florence, Italy
    Arthritis Res Ther 7:R1289-95. 2005
    ....
  8. ncbi Management of post-menopausal osteoporosis: something new on the horizon?
    M L Brandi
    Department of Internal Medicine, University of Florence, Florence, Italy
    J Endocrinol Invest 26:170-3. 2003
  9. ncbi Genetics of hypoparathyroidism and pseudohypoparathyroidism
    M L Brandi
    Unit of Bone and Mineral Metabolism, Department of Internal Medicine, University of Florence, Medical School, Viale Pieraccini, 6 50139 Florence, Italy
    J Endocrinol Invest 34:27-34. 2011
    ..The present article reviews the various disorders related to both hypoparathyroid and pseudohypoparathyroid conditions, with a detailed report of the recent discoveries in term of the genetics of these syndromes...
  10. ncbi Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis
    M L Brandi
    University of Florence Medical School, Florence, Italy
    Curr Med Res Opin 26:2553-63. 2010
    ..Vertebral fractures are common in women with postmenopausal osteoporosis, a chronic condition requiring long-term treatment with anti-osteoporotic treatments. Therefore, it is important to assess sustainability of antifracture efficacy...
  11. ncbi Current treatment approaches for Paget's Disease of Bone
    Maria Luisa Brandi
    Bone and Mineral Metabolic Unit, Department of Internal Medicine and Careggi Hospital, University of Florence, Florence, Italy
    Discov Med 10:209-12. 2010
    ..This article will focus on the present status and future pharmacological developments in PDB...
  12. ncbi An overview of osteoporosis: from genetics to clinics
    Maria Luisa Brandi
    Endocrinology and Metabolic Disorders, Universita degli Studi di Firenze, and Metabolic Bone Disease Department, A O U Careggi, Firenze, Italy
    Aging Clin Exp Res 23:3-5. 2011
    ..In the future, pharmacogenomics will optimize therapy response by customization on the basis of genotype, improving efficacy, and limiting the onset of side effects...
  13. ncbi Guidelines for diagnosis and therapy of MEN type 1 and type 2
    M L Brandi
    Department of Internal Medicine, University of Florence, 50139 Florence, Italy
    J Clin Endocrinol Metab 86:5658-71. 2001
    ....
  14. ncbi Genetics of primary hyperparathyroidism
    Maria Luisa Brandi
    Department of Internal Medicine, University of Florence, Florence, Italy
    Urol Int 72:11-6. 2004
    ..Such mechanisms could, in the near future, become an ideal target for new therapeutic strategies of primary hyperparathyroidism...
  15. ncbi What is the relationship between Paget's disease of bone and hyperparathyroidism?
    Maria Luisa Brandi
    Department of Internal Medicine and DeGene Spin off, University of Florence, Florence, Italy
    J Bone Miner Res 21:P69-74. 2006
  16. ncbi Microarchitecture, the key to bone quality
    Maria Luisa Brandi
    Department of Internal Medicine, University of Florence, Florence, Italy
    Rheumatology (Oxford) 48:iv3-8. 2009
    ....
  17. ncbi FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa
    A Falchetti
    Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
    Calcif Tissue Int 80:15-20. 2007
    ..Our data suggest that FokI VDR polymorphism may contribute to the determination of bone mass and turnover in both pre- and postmenopausal women in this geographically isolated population...
  18. ncbi Relationship of volumetric bone mineral density and structural parameters with ERalpha gene polymorphisms
    C Cepollaro
    Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy
    Calcif Tissue Int 80:307-15. 2007
    ..These results show a relationship between the presence of the P allele and higher values of CtTh in male subjects, indicating for ERalpha a role in the control of tibial bone geometry...
  19. ncbi Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk
    L Masi
    Department of Clinical Physiopathology, University of Florence, Italy
    J Clin Endocrinol Metab 86:2263-9. 2001
    ..1 (95% confidence interval, 1.19-13.87). In conclusion, the aromatase gene can be one of the several genes potentially involved in the maintenance of bone mass and in the regulation of bone mass loss...
  20. ncbi Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease
    M L Brandi
    Department of Clinical Physiopathology, University of Florence, Florence, Italy
    Biochem Biophys Res Commun 265:335-8. 1999
    ..The ERalpha gene appears to interact with the APOE-epsilon4 genotype in determining AD susceptibility...
  21. ncbi Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms
    L Gennari
    Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50135 Florence, Italy
    J Steroid Biochem Mol Biol 81:1-24. 2002
    ....
  22. ncbi Genetics and pharmacogenetics of osteoporosis
    S Carbonell Sala
    Department of Internal Medicine, University of Florence, and DEGENE Srl, Florence, Italy
    J Endocrinol Invest 28:2-7. 2005
    ..Genetic polymorphisms are also starting to be used to predict drug response. A new era of pharmacogenetics represents an interesting prospective to identify the potential individuals to receive customised treatments...
  23. ncbi Microencapsulation of human parathyroid cells: an "in vitro" study
    L Picariello
    Surgery Unit, Department of Clinical Physiopathology, University of Florence, 50139 Florence, Italy
    J Surg Res 96:81-9. 2001
    ..CONCLUSIONS: These findings represent a crucial step toward the construction of functional bioartificial parathyroid organoids for the treatment of hypoparathyroidism in humans...
  24. ncbi Genetic markers of osteoarticular disorders: facts and hopes
    M L Brandi
    Department of Medicine, University of Florence, Viale Morgagni 85, 50135 Florence, Italy
    Arthritis Res 3:270-80. 2001
    ....
  25. ncbi Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study
    S Gonnelli
    Department of Internal Medicine, Endocrine Metabolic Science, and Biochemistry, University of Siena, Policlinico Le Scotte, Viale Bracci 2, 53100 Siena, Italy
    Calcif Tissue Int 87:137-43. 2010
    ..28, and OR = 1.40, CI 1.06-1.82, respectively). In conclusion, in COPD patients high doses of inhaled GCs, but not beta(2) agonists, are associated with an increased risk of vertebral fractures and a reduction of QUS at the calcaneus...
  26. ncbi Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas
    F Massart
    University of Florence, Italy
    Fertil Steril 75:567-70. 2001
    ..To explore a possible association between estrogen receptor-alpha (ER-alpha) gene polymorphisms and development of uterine leiomyomas...
  27. ncbi Binding and bioeffects of Ipriflavone on a human preosteoclastic cell line
    S Benvenuti
    Department of Clinical Physiopathology, University of Florence, School of Medicine, Italy
    Biochem Biophys Res Commun 201:1084-9. 1994
    ..These results demonstrate a direct effect of Ipriflavone and of Metabolite III on the human osteoclast precursor cell line FLG 29.1...
  28. ncbi Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients
    E Luzi
    Department of Internal Medicine, Metabolic Bone Unit, Regional Center for Hereditary Endocrine Tumors, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
    Cancer Gene Ther 17:814-25. 2010
    ..These findings contribute to the understanding of tumorigenesis in MEN1, offering the basis for the development of RNA-based therapies in MEN1 gene mutation carriers...
  29. ncbi The importance of the unsuppressed glands in the study of intact parathyroid hormone disappearance after parathyroid adenomectomy
    F Locchi
    Department of Clinical Physiopathology, State University, Firenze, Italy
    Eur J Endocrinol 144:353-62. 2001
    ..On the contrary, we believe, as do other researchers, that they are not totally suppressed...
  30. ncbi Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors
    Alberto Falchetti
    Regional Centre for Hereditary Endocrine Tumors, Unit of Metabolic Bone Diseases, Department of Internal Medicine, University of Florence, Florence, Italy
    Genet Med 11:825-35. 2009
    ..The ever increrasing combination of genetic and clinical tools will allow early detection of MEN1-associated neoplasms, potentially improving clinical outcomes and quality of life for both affected patients and their relatives...
  31. ncbi Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes
    A Falchetti
    Department of Internal Medicine and Clinical Physiopathology, University of Florence, Florence, Italy
    Ann Endocrinol (Paris) 66:195-205. 2005
    ....
  32. ncbi The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis
    F Marini
    Regional Center for Hereditary Endocrine Tumours, Department of Internal Medicine, University of Florence, Florence, Italy
    J Endocrinol Invest 31:905-9. 2008
    ....
  33. ncbi A comparison of methods for the analysis of low abundance proteins in desmoid tumor cells
    L Picariello
    Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
    Anal Biochem 354:205-12. 2006
    ..The use of a specific and reliable assessment method becomes fundamental in the evaluation of the presence and modulation of proteins which are important but weakly expressed in these rare tumors...
  34. ncbi Genetics of male osteoporosis
    L Gennari
    Dept. of Clinical Physiopathology, University of Florence, Italy
    Calcif Tissue Int 69:200-4. 2001
    ..These observations remain to be confirmed by other independent studies. Other candidate genes, are still awaiting mapping and identification...
  35. ncbi A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis
    L Masi
    Department of Internal Medicine, University Hospital of Florence, Florence, Italy
    J Bone Joint Surg Am 91:1190-8. 2009
    ..Mutational analysis is important for the early recognition of the disorder, for prevention of its complications, and for family screening strategies. We examined two unrelated white patients affected by tumoral calcinosis...
  36. ncbi 2006 update on genetic determinants of osteoporosis
    S Carbonell Sala
    Department of Internal Medicine, School of Medicine, University of Florence, 50139 Florence, Italy
    J Endocrinol Invest 30:2-7. 2007
    ..This paper pretends to give a panoramic on actual genetics of osteoporosis situation, taking into account the most important recent genetic studies in the field...
  37. ncbi Bone mineral density in cystic fibrosis patients under the age of 18 years
    A S Neri
    Cystic Fibrosis Center of Tuscany, Meyer Hospital, Florence, Italy
    Minerva Pediatr 60:147-54. 2008
    ..The increase in life expectancy of cystic fibrosis (CF) patients has brought about a rise in new clinical problems in these patients, such as a decrease in bone mineral density (BMD). The cause of diminished BMD in CF is multi-factorial...
  38. ncbi Physiopathological basis of bone turnover
    L Masi
    Department of Clinical Physiopathology, University of Florence, Italy
    Q J Nucl Med 45:2-6. 2001
    ..Understanding the sequence of cellular events may be important to better know the mechanisms responsible for bone loss that occurs in age and in several pathological conditions...
  39. ncbi TGF-beta isoform and receptor expression in giant cell tumor and giant cell lesions of bone
    A Franchi
    Department of Human Pathology and Oncology, University of Florence Medical School, Italy
    Appl Immunohistochem Mol Morphol 9:170-5. 2001
    ....
  40. ncbi New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures
    R Nuti
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, 53100 Siena, Italy
    J Endocrinol Invest 32:783-8. 2009
    ..This definition does not entirely reflect the spectrum of severity of the disease that provides a variable increase in fracture risk...
  41. ncbi Catecholamines modulate growth and differentiation of human preosteoclastic cells
    U Frediani
    Department of Clinical Physiopathology, University of Florence, Italy
    Osteoporos Int 6:14-21. 1996
    ..1 cells. In differentiated FLG 29.1 cells only IL-6 release was induced by catecholamine treatment. These findings support a potential role for catecholamines in modulating osteoclast differentiation and mature osteoclast activity...
  42. ncbi Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias
    Francesco Tonelli
    Department of Clinical Physiopathology, University of Florence, Medical School, Florence, Italy
    Ann Surg 244:61-70. 2006
    ..The aim of this study was to evaluate the results of pancreatic resection in pancreatic endocrine neoplasias (PENs) in patients affected by multiple endocrine neoplasia type 1 (MEN1) syndrome...
  43. ncbi Pharmacogenetics of osteoporosis: future perspectives
    Francesca Marini
    Mineral and Bone Metabolism Unit, Department of Internal Medicine, University of Florence, Florence, Italy
    Calcif Tissue Int 84:337-47. 2009
    ..In this paper we review the most recent data on pharmacogenetics of osteoporosis, highlighting the presentations at the Second International Meeting on Pharmacogenetics of Osteoarticular Disorders held in Florence in April 2008...
  44. ncbi Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study
    Vincenzo de Giorgi
    Department of Dermatology, University of Florence, Via della Pergola 60, 50121 Florence, Italy
    Arch Dermatol 145:30-6. 2009
    ..To evaluate estrogen receptor (ER) expression in human melanoma tissues and in the adjacent healthy skin with the aim of explaining whether the ERalpha:ERbeta expression ratio has a role in neoplastic progression...
  45. ncbi Somatostatinoma: clinico-pathological features of three cases and literature reviewed
    Gabriella Nesi
    Department of Human Pathology and Oncology, University of Florence, Florence, Italy
    J Gastroenterol Hepatol 23:521-6. 2008
    ..A comparison between our three cases and those in the literature provides useful insights into the clinical management of these patients. Interestingly, the jejunal somatostatinoma described here is the second case ever reported...
  46. ncbi Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?
    Francesco Tonelli
    Department of Clinical Physiopathology, University of Florence, Medical SchoolFlorence, Italy
    Ann Surg 246:1075-82. 2007
    ..The aim of the present report is to describe the results obtained with total parathyroidectomy (TPTX) guided by rapid intraoperative parathyroid hormone (PTH) evaluation, followed by immediate parathyroid autograft with fresh tissue...
  47. ncbi Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone
    Alberto Falchetti
    Department of Internal Medicine, University of Florence, Florence, Italy
    Calcif Tissue Int 84:20-37. 2009
    ..This may be helpful in estimating the true rate of de novo mutations. We confirm the data on the existence of both a mutational hotspot at the UBA domain of SQSTM1/p62 and a founder effect in the PDB population...
  48. ncbi A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism
    Luigi Gennari
    Department of Internal Medicine, University of Florence, 50139 Florence, Italy
    J Clin Endocrinol Metab 89:2803-10. 2004
    ..In conclusion, differences in estrogen levels due to polymorphism at the aromatase CYP19 gene may predispose men to increased age-related bone loss and fracture risk...
  49. ncbi Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
    Laura Masi
    Department of Internal Medicine, University of Florence, Florence, Italy
    J Rheumatol 31:986-91. 2004
    ....
  50. ncbi Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders
    Valentina Ghinoi
    Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
    Expert Opin Pharmacother 3:1643-56. 2002
    ..However, studies that demonstrate an effect on the rate of fractures are needed before any recommendation can be made...
  51. ncbi Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement
    Gabriele Simonini
    Department of Paediatrics, Rheumatology Unit, University of Florence, Florence, Italy
    J Rheumatol 32:2233-8. 2005
    ..We evaluated serum levels of OPG in a group of children with Kawasaki disease (KD), before immunoglobulin (IVIG) infusion and at 3-month followup...
  52. ncbi Dynamic investigation for evaluation of calcium metabolism and parathyroid function
    F Cioppi
    Department of Internal Medicine, University of Florence, Florence, Italy
    J Endocrinol Invest 26:83-91. 2003
    ..Only in selected conditions, here briefly reviewed, dynamic tests can offer an interpretation on the pathogenetic events causing a disorder of calcium metabolism...
  53. ncbi Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women
    L Masi
    Department of Clinical Physiopathology, University of Florence, Italy
    Biochem Biophys Res Commun 245:622-6. 1998
    ..In addition, Duncan's test used to compare the genotypes showed that TT genotype has significant lower lumbar BMD in comparison with CC genotype...
  54. ncbi Multiple endocrine neoplasms
    Alberto Falchetti
    Surgery Unit, Department of Clinical Physiopathology, University of Florence, 6 50139 Florence, Italy
    Best Pract Res Clin Rheumatol 22:149-63. 2008
    ..If not diagnosed precociously, MTC can be fatal. MEN1 develops after tissue inactivation of both MEN1 gene copies. Activating mutations of c-RET proto-oncogene causes MEN2...
  55. ncbi Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis
    Laura Masi
    A Meyer Children s Hospital, University of Florence, Firenze, Italy
    J Rheumatol 36:2308-13. 2009
    ..To evaluate if serum concentrations of osteopontin (OPN) at baseline in patients with juvenile idiopathic arthritis (JIA) represent a potential predictor of responsiveness to methotrexate (MTX)...
  56. ncbi Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma
    G Galli
    Department of Internal Medicine, University of Florence Medical School, Viale Pieraccini 6, 50139 Florence, Italy
    Endocr Relat Cancer 13:79-93. 2006
    ..Based on these findings, the potential of SST analogues, IFN-gamma and AZT, alone or in combination, should be further explored in the medical treatment of somatostatinoma...
  57. ncbi Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience
    F Tonelli
    Department of Clinical Physiopathology, University of Florence, Florence, Italy
    J Intern Med 257:38-49. 2005
    ..Endoscopic removal is possible for lesions growing in the mucosa-submucosa, but partial or even total gastrectomy is recommended for the small number of gastric carcinoids infiltrating the muscular layers...
  58. ncbi Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care
    F Lapi
    Department of Preclinical and Clinical Pharmacology, University of Florence, Italy
    Bone 50:85-90. 2012
    ..To assess the gender and age-related 5-year incidence rates of osteoporotic fractures, and their related predictors, in a primary care setting...
  59. ncbi Molecular, biochemical and cellular biology of PTH anabolic action
    L Masi
    Department of Internal Medicine, University of Florence, Florence, Italy
    J Endocrinol Invest 28:37-40. 2005
    ..PTH (1-34) is currently being safely and effectively used in osteoporosis, and together with novel PTH derivates agent provides more tools for the clinicians in their armamentarium for the fight against osteoporosis...
  60. ncbi Growth response of colon cancer cell lines to selective estrogen receptor modulators
    Lucia Picariello
    Department of Clinical Physiopathology, University of Florence, Florence, Italy
    Anticancer Res 23:2419-24. 2003
    ..CONCLUSION: Tamoxifen, and even more raloxifene, were effective in reducing HCT8 and HCT116 cell proliferation and viability, suggesting their potential application in the prevention and therapy of colorectal cancer...
  61. ncbi Estrogen metabolism in human colorectal cancer cells
    G Fiorelli
    Department of Clinical Physiopathology, University of Florence, Florence, Italy
    J Steroid Biochem Mol Biol 81:281-9. 2002
    ..In conclusion, our results clearly show that metabolism of estrogens by 17betaHSD isoenzymes is functional and modulated by external stimuli in continuous neoplastic colonic epithelial cell lines...
  62. ncbi Calcium modulates the cyclin D1 expression in a rat parathyroid cell line
    S Bianchi
    Department of Clinical Physiopathology, University of Florence, Italy
    Biochem Biophys Res Commun 204:691-700. 1994
    ..Increasing amounts of calcium in the incubation medium reduced the expression of rat cyclin D1 and D2. The effect appears to be cell-specific and probably mediated through the inhibition of mitogenic signalling pathways...
  63. ncbi Paget's disease of bone: there's more than the affected skeletal--a clinical review and suggestions for the clinical practice
    Alberto Falchetti
    Regional Center for Hereditary Endocrine Tumors, Department of Internal Medicine, University of Florence, Florence, Italy
    Curr Opin Rheumatol 22:410-23. 2010
    ..A practical suggestion for an optimal management path of Paget's disease of bone is given...
  64. ncbi Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
    Sandra Silvestri
    Department of Internal Medicine, School of Medicine, University of Florence, Florence, Italy
    Menopause 13:451-61. 2006
    ..In another untreated subpopulation of 443 women, genotype influence on the prevalence of vertebral fractures and on annual rate of bone loss during a mean follow-up period of 11 years was estimated...
  65. ncbi Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis
    Francesca Marini
    Department of Internal Medicine, University of Florence, Florence, Italy
    Curr Med Res Opin 24:2609-15. 2008
    ..Polymorphisms of genes encoding enzymes of the mevalonate pathway could modulate the response to amino-bisphosphonate treatment in postmenopausal osteoporosis...
  66. ncbi In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture
    Isabella Tognarini
    Department of Internal Medicine, University of Florence Medical School, Florence, Italy
    Cell Oncol 32:331-43. 2010
    ..The controversial expression of oestrogen receptors (ERs) in SPNs, provide a rationale for studying the effects of oestrogenic molecules on SPN development...
  67. ncbi Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report
    Laura Papi
    Medical Genetics Unit, Department of Clinical Pathophysiology, University of Florence, Florence, Italy
    Cancer Genet Cytogenet 195:75-9. 2009
    ..We explore genetic and molecular rationales for an association between these neoplastic processes...
  68. ncbi Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis
    Laura Masi
    Department of Pediatrics, University of Florence, Florence, Italy
    J Rheumatol 29:2225-31. 2002
    ..To compare bone density with polymorphisms in the calcitonin receptor (CTR) and vitamin D receptor (VDR) genes in 50 patients with juvenile idiopathic arthritis and 80 matched controls...
  69. ncbi A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet
    Alberto Falchetti
    University Hospital of Careggi, Florence, Italy
    Nat Clin Pract Endocrinol Metab 4:351-7. 2008
    ..MEN1 was confirmed by analysis of the MEN1 gene, which revealed a 1555insG frameshift mutation. In 2006 serum calcium and parathyroid hormone (PTH) levels were again found to be high...
  70. ncbi Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene
    Francesco Tonelli
    Department of Clinical Physiopathology, University of Florence, Italy
    Tumori 89:391-6. 2003
    ..These findings offer a novel option in the pharmacological treatment of desmoids, leading to medical therapy of these neoplastic lesions in familial adenomatous polyposis patients...
  71. ncbi Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture
    Alberto Falchetti
    Department of Internal Medicine, University of Florence, Florence, Italy
    J Bone Miner Res 20:410-8. 2005
    ....
  72. ncbi In vitro differentiation of human mesenchymal stem cells on Ti6Al4V surfaces
    Isabella Tognarini
    Department of Internal Medicine, Medical School, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
    Biomaterials 29:809-24. 2008
    ..In conclusion, adipose tissue is a promising autologous source of osteoblastic cells with important clinical implications for bone tissue engineering...
  73. ncbi Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases
    Francesco Sofi
    Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
    Nutr Metab Cardiovasc Dis 16:436-44. 2006
    ..The aims of this study were to evaluate dietary habits, and to assess the adherence of the general population to the recommendations for correct nutritional behaviour...
  74. ncbi Selective oestrogen receptor modulators in desmoid tumours
    Lucia Picariello
    Department of Clinical Physiopathology, University of Florence, Italy
    Expert Opin Investig Drugs 13:1457-68. 2004
    ..The knowledge of the molecular basis of SERM action will make the development of novel synthetic compounds with engineered tissue selectivity possible...
  75. ncbi ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components
    Valentina Martineti
    Department of Internal Medicine, School of Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
    Endocr Relat Cancer 12:455-69. 2005
    ..These findings are compatible with the hypothesis that the loss of ERbeta expression could be one of the events involved in the development or progression of colon cancer...
  76. ncbi Papillary thyroid carcinoma
    Cetta Francesco
    Am J Surg Pathol 27:1176-7. 2003
  77. ncbi Determinants of bone turnover markers in healthy premenopausal women
    Silvano Adami
    Rheumatology Unit, University of Verona, Ospedale di Valeggio, Valeggio, Verona, Italy
    Calcif Tissue Int 82:341-7. 2008
    ..New normative ranges for serum OC, CTX, and P1NP were identified; and our findings in general impose a redefinition of the criteria for establishing the normal ranges for BTMs...
  78. ncbi Intravenous zoledronic acid in postmenopausal women with low bone mineral density
    Ian R Reid
    Department of Medicine, University of Auckland, Auckland, New Zealand
    N Engl J Med 346:653-61. 2002
    ..Gastrointestinal intolerance limits maximal dosing. Although intermittent intravenous treatments have been used, the optimal doses and dosing interval have not been systematically explored...
  79. ncbi Myostatin polymorphisms and age-related sarcopenia in the Italian population
    Anna Maria Corsi
    J Am Geriatr Soc 50:1463. 2002
  80. ncbi Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients
    Giuseppe Vezzoli
    Division of Nephrology Dialysis and Hypertension, Postgraduate School of Nephrology, Ateneo Vita e Salute, IRCCS San Raffaele Hospital, Milan, Italy
    J Am Soc Nephrol 13:2517-23. 2002
    ..Arg990Gly polymorphism could facilitate activation of CaSR and increase Ca excretion and susceptibility to idiopathic hypercalciuria...
  81. ncbi Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm
    Chiara Armani
    Cardiac and Thoracic Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
    Biomed Pharmacother 61:268-71. 2007
    ..We compared the results with those of 156 healthy subjects. No difference was found in the allelic distribution of either polymorphisms. We therefore found no evidence that MMP-9 is a marker of susceptibility for AAA...
  82. ncbi Evidence of sexual dimorphism in relationships between estrogen receptor polymorphisms and bone mass: the Hertfordshire study
    Elaine Dennison
    MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton, England
    J Rheumatol 32:2400-4. 2005
    ..To examine the relationship between estrogen receptor (ER) a and ss gene polymorphisms and bone mass...
  83. ncbi Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis
    Stefano Luisi
    Department of Pediatrics, Gynecology and Reproductive Medicine, University of Siena, Siena, Italy
    Fertil Steril 85:764-6. 2006
    ....
  84. ncbi Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study
    Stuart H Ralston
    Rheumatic Diseases Unit, University of Edinburgh, Western General Hospital Edinburgh, Edinburgh, United Kingdom
    PLoS Med 3:e90. 2006
    ....
  85. ncbi Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas)
    Robert T Jensen
    Digestive Diseases Branch, NIDDK, NIH, Bethesda, MD, USA
    Neuroendocrinology 84:165-72. 2006
  86. ncbi Pharmacogenetics of bone treatments: the VDR and ERalpha gene story
    Francesco Massart
    Department of Pediatrics, University of Pisa, Pisa, Italy
    Pharmacogenomics 9:733-46. 2008
    ..g., VDR or ERalpha). Because of their specific ethnic distribution, VDR and ERalpha polymorphisms may be involved in reported human differences of osteoporosis treatment responses...
  87. ncbi Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis
    John P A Ioannidis
    Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece
    J Bone Miner Res 17:2048-60. 2002
    ..In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism is not associated with either BMD or fracture risk...
  88. ncbi Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm
    Francesco Massart
    Pediatric Endocrine Center, Department of Pediatrics, University of Pisa, Via Roma 67, 56125 Pisa, Italy
    J Steroid Biochem Mol Biol 92:413-8. 2004
    ..However, because possessing at least an ERbetaAluI restriction site was statistically associated to AAA onset (chi(2) = 5.220; OR = 1.82, P < 0.05), ERbeta polymorphism was proposed as genetic determinant in the AAA susceptibility...
  89. ncbi Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes
    John P A Ioannidis
    Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
    JAMA 292:2105-14. 2004
    ..Estrogen receptor alpha (ESR1) is a candidate gene for osteoporosis, but previous studies of ESR1 polymorphisms in this field were hampered by small sample size, lack of standardization, and inconclusive results...
  90. ncbi Isolation and characterization of a new cell line from a renal carcinoma bone metastasis
    Sofia Avnet
    Laboratory for Pathophysiology of Orthopedic Implants, Istituti Ortopedici Rizzoli, Bologna, Italy
    Anticancer Res 24:1705-11. 2004
    ....
  91. ncbi Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study
    Bente L Langdahl
    Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark
    Bone 42:969-81. 2008
    ....
  92. ncbi Calcium bioavailability from a calcium-rich mineral water, with some observations on method
    Lucia Bacciottini
    Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
    J Clin Gastroenterol 38:761-6. 2004
    ..DISCUSSION: The calcium from the mineral water is thus highly bioavailable, at least as bioavailable as milk calcium, and ICP-MS appears to represent a reliable and reproducible method for calcium absorption from alimentary sources...
  93. ncbi Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia
    Yasuo Imanishi
    Center for Molecular Medicine, University of Connecticut Health Center, Farmington, Connecticut 06030-3101, USA
    J Am Soc Nephrol 13:1490-8. 2002
    ....